Low seroprevalence of neutralizing antibodies to adeno-associated virus serotype 9 in preparation for MyPEAK-1 study of TN-201 for individuals with MYBPC3-associated hypertrophic cardiomyopathy
Speaker:
Professor N. Paterson (South San Francisco, US)